6-K - Novo Nordisk A/S | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Novo Nordisk A/S reports transactions under its share repurchase programme initiated on 4 February 2026, with 6,577,992 B shares repurchased for DKK 1,783,540,174 at an average price of DKK 271.14 as of 13 March 2026. This is part of a DKK 15 billion programme over 12 months, resulting in 23,967,791 treasury B shares equal to 0.5% of share capital.

Key Takeaways

1Share repurchase programme initiated 4 February 2026 for up to DKK 15 billion over 12 months.

2Current tranche up to DKK 3.8 billion from 4 February 2026 to 4 May 2026.

3Repurchased 6,577,992 B shares since 4 February 2026 at average DKK 271.14 per share, total DKK 1,783,540,174.

4Transactions 9-13 March 2026: 248,000 shares on 9 Mar (DKK 62,363,805), 245,000 on 10 Mar (DKK 61,541,030), 250,000 each on 11-13 Mar (DKK 62,207,045; 62,394,702; 62,236,498).

5Owns 23,967,791 B shares as treasury shares (0.5% of share capital).

6Total A and B shares: 4,465,000,000 including treasury shares.

Current Report Details

Event Type

Securities Issuance

Disclosure

Voluntary

Variant

6-K

Items Reported

6-K

Current Report on Form 6-K

Securities Issuance

Capital Return

Buyback Auth.

DKK 15 billion over 12-month period beginning 4 February 2026

Exhibits (1)

6-K

FORM 6-K